Vice President Digital Marketing

CHRISTINA Y. FUNDERBURK

973-***-**** christinafunderburk.com ********************@*****.***

SUMMARY

Data-Driven Global Marketing Leader with 10+ years advancing oncology and rare disease commercialization strategies. Expertise in unlocking market access, scaling revenue via AI-powered insights, and leading cross-functional teams for Fortune 500 biopharma clients.

Key Achievements:

Delivered $6.3M+ in annual revenue growth through predictive analytics and market gap identification.

Drove 35% faster campaign cycles and 8% market share gains in ultra-rare diseases via compliant, multi-channel activation.

Built AI-driven frameworks (Blackbird AI, IBM Watson) to mitigate misinformation risk and accelerate HCP adoption.

AREAS OF EXPERTISE

Business Leadership: Strategic Planning Market Research P&L Management C-Suite Advisory

Technical Skills: AI/ML Analytics SEO/SEM Content Strategy Video Production & Editing Digital Marketing

Domain Knowledge: Oncology/Rare Disease Market Access DTC/HCP Engagement Global Launch Strategy Crisis Communications

PROFESSIONAL EXPERIENCE

Vice President, Strategic Planning — Weber Shandwick 2022 – Present

Global Oncology/Rare Disease Strategy: Orchestrate end-to-end commercialization for 15+ therapies leveraging AI-driven sentiment tracking (Blackbird AI) to counteract misinformation by 22% and protect brand equity.

Revenue Growth: Identified underpenetrated markets for a key sickle cell disease therapy, deploying real-time analytics to secure $4M in incremental annual revenue.

Operational Efficiency: Reduced campaign cycle times by 15% via an integrated analytics framework adopted enterprise wide.

Vice President, Digital Strategy Lead — Syneos Health 2022

Brand Launch/ Market Access: Led global DTC/HCP strategy for 3 blockbuster therapies translating real-world data into actionable insights that closed treatment gaps for 50K+ patients.

Revenue Impact: Drove 8% market share growth ($4M annual revenue) through hyper-targeted messaging aligned with revised CMS reimbursement guidelines.

Vice President, Content & Channel Strategy — WE Communications 2021

New Business Growth: Capitalized on post-pandemic telehealth demand to design 12 omnichannel campaigns (video, SEM, earned media), securing $2.3M in new pharma contracts.

KEY PROJECTS

Ultra-Rare Disease Market Expansion (PKD/MD):

Spearheaded patient identification initiative using geospatial analytics, increasing HCP engagement by 40% in rural regions.

Partnered with advocacy groups to design compliant DTC campaigns, boosting clinical trial sign-ups by 25.

Campaign nominated for multiple awards

TECHNICAL SKILLS & TOOLS

AI/Analytics: Blackbird AI, IBM Watson, Google Analytics, Meltwater

Digital Marketing: Adobe Premiere, Canva, HubSpot, WordPress, SEMRush

Compliance: Veeva PromoMats, MLR review processes

EDUCATION

MBA, Digital Marketing & Entrepreneurship Strayer University

B.A., Humanities, Art History minor Montclair State University

Contact this candidate